Glaucoma is a progressive, irreversible optic neuropathy causing a gradual loss of ganglion cell axons. Early detection is therefore essential to begin administering pressure-reducing treatment to stop or delay progressive loss of visual function.
1 In clinical practice, glaucoma diagnosis is performed using ophthalmoscopic examination of the optic nerve head, examination of the retinal nerve fiber layer (RNFL), and visual field testing with standard automatic perimetry. The evaluation of the structural changes using spectral-domain optical coherence tomography (SD-OCT) plays an important role in the diagnosis and treatment of glaucomatous patients. Because glaucoma primarily affects retinal ganglion cells and their axons, up to this point, most OCT studies have used circumpapillary retinal nerve fiber layer (cpRNFL) thickness measurements to detect glaucoma. Furthermore, some studies have already shown that the macular ganglion cell complex (GCC) has a good glaucoma-discriminating power that is comparable with that of the RNFL.
2–6 Recent advances in OCT technology have allowed for an automatic segmentation between the RNFL and the ganglion cell layer (GCL) at the macula.
7
SD-OCT devices are commercially available from several different companies. The speed and resolution of image acquisition varies between instruments, despite similar working principles. Two studies revealed that the cpRNFL measurements from healthy controls using various devices were different and not comparable.
8,9 Additionally, Leite et al. and one of our previous studies made interinstrumental comparisons between SD-OCT devices to diagnose glaucomatous optic neuropathy. However, both studies excluded highly myopic eyes.
10,11
Myopia is reported as a common ocular abnormality worldwide, and it is an independent risk factor for glaucoma.
12 Although diagnosing glaucoma in myopic subjects is important in clinical practice, structural changes related to myopia—such as tilting, optic disc deformation, shallow cup, and large peripapillary crescent—disturb the precise diagnosis of glaucoma.
13,14 The clinical diagnosis of glaucoma in such patients, especially in these patients without advanced visual field loss, is challenging because the optic disc appearance is often unusual and difficult to assess. As the normative database of SD-OCT instruments largely comprises data collected from normal eyes with no or low myopia, interpreting the RNFL thickness (RNFLT) deviation map in eyes with high myopia can be problematic. Several studies have demonstrated that myopic eyes have thinner RNFL measurements and a unique pattern of RNFL distribution, leading to inaccurate diagnosis by OCT.
15–20 However, a few studies have demonstrated the diagnostic abilities of OCT measurements for glaucoma in highly myopic eyes.
21–24 One group reported that the GCC thickness measured with RTVue was superior to the cpRNFL thickness for detecting glaucoma in highly myopic patients,
22,23 while another group reported no significant difference in the detection ability between cpRNFL and GCC thickness.
21,24 There are no reports that have compared the cpRNFL thickness and macular parameters at the same time among several SD-OCT instruments in a single population consisting of highly myopic patients.
This study assessed the diagnostic ability of the cpRNFL thickness and the macular parameters evaluated by Cirrus, RTVue, and 3D OCT to detect highly myopic glaucomatous eyes.